Target intelligence / Profile preview

Retinol-binding protein 3 (RBP3)

Target
RBP3
Molecular classification
Other (retinoid transporter; large glycoprotein; non-enzymatic binding/transport protein)
01

Overview

Retinol-binding protein 3 (RBP3), also known as interphotoreceptor retinoid-binding protein (IRBP), is a large glycoprotein found in the interphotoreceptor matrix of the eye, specifically between retinal pigment epithelium and photoreceptor cells. Structurally, RBP3 consists of four tandem retinoid-binding modules and can bind multiple retinoids and fatty acids, including all-trans-retinol and 11-cis-retinal, as well as docosahexaenoic acid. RBP3 acts as a transporter, shuttling retinoids between photoreceptors and retinal pigment epithelium, which is crucial for regenerating visual pigments during the visual cycle. Its conformational flexibility allows dynamic adaptation to different ligands, which is vital for efficient transport. Disruption or loss of RBP3 expression is linked to several retinal diseases, such as diabetic retinopathy, retinitis pigmentosa, and myopia. It is not a drug target in the classic therapeutic sense (such as a receptor or enzyme), and there are currently no drugs directly targeting it, but its levels may serve as a biomarker for ocular health and disease progression[1][2][3][4].

Other names
Interphotoreceptor retinoid-binding proteinIRBPD10S64D10S65D10S66RP66Interstitial retinol-binding protein
02

Biological functions

Retinoid transport between retinal photoreceptors and pigment epitheliumBinding and transport of retinoids (all-trans-retinol, 11-cis-retinal)Binding and possible transport of fatty acids (e.g., docosahexaenoic acid)Protection of photoreceptors from photodegradationRegulation of the visual cycle
03

Disease associations

Diabetic retinopathyRetinitis pigmentosaPan-retinal degenerationMyopia
04

Safety considerations

Disrupted or decreased RBP3 associated with retinal degeneration and vision loss
05

Biomarkers

RBP3 levels (biomarker for severity/progression of diabetic retinopathy and other retinal degenerative diseases)

Beyond the preview

Go deeper on Retinol-binding protein 3 (RBP3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Retinol-binding protein 3 (RBP3).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call